About Apervita
Apervita is a Healthcare company based in Chicago (United States) founded in 2011. Analytics platform for for reducing readmission, disease risks and improving compliance. It operates in the Healthcare and Technology sectors. Apervita has raised $43.55 million across 6 funding rounds from investors including Wintrust, General Electric and Baird Capital. Apervita has completed 1 acquisition, including Qcentive. Its focus areas include Enterprise Applications, Vertical Business Intelligence, Industry Specific and HealthTech. Its competitors include Komodo Health, FICO and Stratasan; 2 of its 3 listed competitors have raised funding.
Company details
Apervita enables health professionals and enterprises to upload health data on patients, performance, utilization, medication, billing, and claims to their platform. Users can secure, share, publish data in the Apervita marketplace for anyone to purchase. Institutes and Researchers can turn their paper-based medical algorithms into computable insights on readmission, compliance, and disease-specific insights, then share or commercialize them. It also allows providers, payers pharma players to take control of safety, quality, and enterprise performance. Users can see all their metrics in one place, monitor public reputation, share performance across teams, and access tools to drive improvement.
- Headquarters Chicago, United States
- SectorsHealthcareTechnology
- Website apervita.com
- Social LinkedIn X
Funding Insights of Apervita
Apervita has successfully raised a total of $43.55M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $22.56 million completed in October 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $43.55M
- Total Rounds 6
- Last Round Series B — $22.56M
- First Round $1.59M
(Dec 2012)
- Investors Count 7
All 6 funding rounds of Apervita with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2019 | $22.56M | Series B | – | Baird Capital, Pritzker Group | |
| Jan 2015 | $18M | Series A | – | Baird Capital, General Electric | |
| Jun 2013 | $1.4M | Debt – Conventional | – | – | – |
| Jun 2013 | $1.4M | Seed | – | – | – |
| Dec 2012 | $1.59M | Debt – Conventional | – | – | – |
| Dec 2012 | $1.59M | Seed | – | – | – |
7 investors in total: 7 institutional.
Investors in Apervita
Apervita has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Wintrust, General Electric and Baird Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Global private equity and venture capital investments in B2B Tech & Services companies. | bairdcapital.com | |||
Investments in SaaS, marketplace, and middle market companies are managed. | pritzkergroup.com | Chicago, United States | ||
Early-stage tech and offline focused VC firm funding companies in the US | optumventures.com | Boston, United States | ||
Early-stage tech startups are invested in across US and Canada. | mathventurepartners.com | Chicago, United States | ||
Early-stage investments are made in deep tech sectors. | illinoisventures.com | Champaign, United States | ||
Bank offering diversified financial services | 1991 | wintrust.com | Rosemont, United States | |
Diversified operations are conducted across multiple industries worldwide. | 1892 | ge.com | United States |
Investor details for Apervita
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Apervita
Apervita has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Qcentive.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Outsourced management of value-based payment programs is provided. | qcentive.com | Boston, United States | 2016 | Aug 2019 | •••• |
Complete acquisition details for Apervita
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Apervita
4 dated milestones of Apervita across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Apervita is founded.
- Funding First funding round of $1.6M.
- Acquisition Acquires Qcentive.
- Funding Latest funding round, Series B, of $22.6M.
Competitors of Apervita
Apervita has 3 listed competitors in our database, 2 of them funded. They include Komodo Health, FICO and Stratasan.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| komodohealth.com | 2014 | New York, United States | $514M | 269 | Data-driven insights are delivered to healthcare via AI platforms. | |
| fico.com | 1956 | San Jose, United States | 4,003 | Analytics software and tools are provided for business decision-making. | ||
| stratasan.com | 2010 | Nashville, United States | $27.18M | Healthcare market intelligence is delivered through a SaaS platform. |
Detailed competitors of Apervita
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Apervita (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Apervita
Complete news archive for Apervita
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Apervita
Apervita was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Apervita is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.
Apervita is a funded company, having raised a total of $43.55M across 6 funding rounds to date. The company's 1st funding round was a Seed of $1.59M, raised on Dec 2012.
Apervita enables health professionals and enterprises to upload health data on patients, performance, utilization, medication, billing, and claims to their platform. Users can secure, share, publish data in the Apervita marketplace for anyone to purchase. Institutes and Researchers can turn their paper-based medical algorithms into computable insights on readmission, compliance, and disease-specific insights, then share or commercialize them. It also allows providers, payers pharma players to take control of safety, quality, and enterprise performance. Users can see all their metrics in one place, monitor public reputation, share performance across teams, and access tools to drive improvement.
Apervita's top competitors include Komodo Health, FICO and Stratasan.
Apervita has made 1 acquisition, including Qcentive.
Apervita has 7 investors. Key investors include Wintrust, General Electric, Baird Capital, Pritzker Group, and Optum Ventures.